ANDA 87440, held by Luitpold Pharmaceuticals. Dexamethasone Sodium Phosphate.
As of Nov 21, 2026, ANDA 87440 (Dexamethasone Sodium Phosphate), held by Luitpold Pharmaceuticals, was first approved by FDA on Jul 21, 1982, with 18 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 21, 1982 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dexamethasone Sodium PhosphateEQ 4MG PHOSPHATE/ML · injectable;injection | Dexamethasone Sodium Phosphate | DiscontinuedReference drug |
| Jul 3, 2014 | Supplement 27Labeling · Standard review | Approved | None posted |
| Aug 31, 2001 | Supplement 20Manufacturing | Approved | None posted |
| May 7, 2001 | Supplement 19Manufacturing | Approved | None posted |
| Sep 17, 1997 | Supplement 18Manufacturing | Approved | None posted |
| Sep 16, 1996 | Supplement 17Labeling | Approved | None posted |
| Feb 28, 1996 | Supplement 16Manufacturing | Approved | None posted |
| Oct 27, 1995 | Supplement 14Labeling | Approved | None posted |
| Mar 11, 1993 | Supplement 15Manufacturing | Approved | None posted |
| Jan 16, 1991 | Supplement 11Manufacturing | Approved | None posted |
| Jan 16, 1991 | Supplement 12Manufacturing | Approved | None posted |
| Oct 2, 1989 | Supplement 13Labeling | Approved | None posted |
| Apr 8, 1988 | Supplement 10Manufacturing | Approved | None posted |
| Apr 7, 1988 | Supplement 9Manufacturing | Approved | None posted |
| Sep 14, 1984 | Supplement 5Manufacturing | Approved | None posted |
| Sep 14, 1984 | Supplement 6Manufacturing | Approved | None posted |
| May 9, 1983 | Supplement 1Manufacturing | Approved | None posted |
| May 9, 1983 | Supplement 3Manufacturing | Approved | None posted |
| May 9, 1983 | Supplement 4Manufacturing | Approved | None posted |
| Jul 21, 1982 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters